Outcomes Seem No Worse With Stereotactic RT for Brain Mets in SCLC

THURSDAY, June 2, 2022 -- For patients with small cell lung cancer (SCLC) with intracranial metastatic disease (IMD), outcomes appear to be no worse with stereotactic radiosurgery (SRS) compared with whole brain radiotherapy (WBRT), according to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news